Abstract
The possibility that interferon (IFN) and antibody could act together to reduce virus yields in infected cells was suggested by the simultaneous occurrence of IFN and antibody at infected sites. In the present in vitro studies, mixtures of IFNs and antibody acted synergistically to reduce virus yields in cultures infected with coxsackievirus A24, enterovirus 70, adenovirus, and herpes simplex virus. This synergistic reduction was observed in different cells and at different concentration of IFN and antibody. Although IFN and antibody acted synergistically against all viruses tested, the degree of synergism was dependent on the type of IFN or the virus. For example, IFN-beta and antibody was 10 to 200 times more effective than IFN-gamma and antibody against coxsackievirus A24, enterovirus 70, and adenovirus. A combination of antibody and IFN-gamma was three to five times more effective than IFN-beta and antibody against herpes simplex virus. In addition, we found that endogenously produced IFN-beta could act synergistically with antibody to coxsackievirus A24 to increase the overall antiviral effect by 10(5.0)-fold. No effect of endogenous IFN was observed in herpes simplex virus-infected cultures treated with antibody to herpes simplex virus. These studies indicate the potential importance of the synergistic effect of locally produced IFN and antibody in restricting virus early in the natural infectious process. They also suggest that combinations of IFNs and antibody may be more beneficial in the treatment of certain virus infections than IFN or antibody alone.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Langford M. P., Georgiades J. A., Stanton G. J., Dianzani F., Johnson H. M. Large-scale production and physicochemical characterization of human immune interferon. Infect Immun. 1979 Oct;26(1):36–41. doi: 10.1128/iai.26.1.36-41.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Langford M. P., Stanton G. J., Barber J. C., Baron S. Early-appearing antiviral activity in human tears during a case of picornavirus epidemic conjunctivitis. J Infect Dis. 1979 Jun;139(6):653–658. doi: 10.1093/infdis/139.6.653. [DOI] [PubMed] [Google Scholar]
- Langford M. P., Weigent D. A., Stanton G. J., Baron S. Virus plaque-reduction assay for interferon: microplaque and regular macroplaque reduction assays. Methods Enzymol. 1981;78(Pt A):339–346. doi: 10.1016/0076-6879(81)78139-4. [DOI] [PubMed] [Google Scholar]
- Langford M. P., Yin-Murphy M., Ho Y. M., Barber J. C., Baron S., Stanton G. J. Human fibroblast interferon in tears of patients with picornavirus epidemic conjunctivitis. Infect Immun. 1980 Sep;29(3):995–998. doi: 10.1128/iai.29.3.995-998.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stanton G. J., Johnson H. M., Baron S. The role of interferon in virus infections and antibody formation. Pathobiol Annu. 1978;8:285–313. [PubMed] [Google Scholar]
- Stanton G. J., Langford M. P., Baron S. Effect of interferon, elevated temperature, and cell type on replication of acute hemorrhagic conjunctivitis viruses. Infect Immun. 1977 Nov;18(2):370–376. doi: 10.1128/iai.18.2.370-376.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weiner L. S., Howell J. T., Langford M. P., Stanton G. J., Baron S., Goldblum R. M., Lord R. A., Goldman A. S. Effect of specific antibodies on chronic echovirus type 5 encephalitis in a patient with hypogammaglobulinemia. J Infect Dis. 1979 Dec;140(6):858–863. doi: 10.1093/infdis/140.6.858. [DOI] [PubMed] [Google Scholar]
- Yin-Murphy M. The picornaviruses of acute haemorrhagic conjunctivitis: a comparative study. Southeast Asian J Trop Med Public Health. 1973 Sep;4(3):305–310. [PubMed] [Google Scholar]